Dr. Stancovski is a senior pharmaceutical consultant with over 20 years’ experience in the life sciences industry. She has worked in senior leadership positions across disciplines including preclinical and clinical drug development, project and portfolio management, regulatory and medical affairs in large international pharmaceutical companies (Pfizer, Actavis Group, Mayne Pharma) and biotech companies. Ilana has served as an adviser for pharma and biotech companies and assisted clients across a broad range of therapeutic areas, from early stages of drug discovery to commercialization. In addition, Ilana has supported investment funds, venture capitals and pharma companies in evaluating investment opportunities. Ilana has a PhD in Life Sciences from the Weizmann Institute, Israel and worked as a post-doctoral scholar at Caltech and MIT in the United States.